Novartis AG vs AstraZeneca PLC
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
AstraZeneca PLC currently has the stronger revenue growth signal.
Novartis AG and AstraZeneca PLC show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Novartis AG | AstraZeneca PLC |
|---|---|---|
| Current Price | ₹151.4 | ₹185.33 |
| Market Cap | ₹2.89 L Cr. | ₹5.75 L Cr. |
| Industry | Pharmaceuticals | Pharmaceuticals |
| P/E Ratio | 21.604586 | 28.148872 |
| ROE (%) | — | — |
| Debt/Equity | — | — |
| Sales Growth 5Y (%) | — | — |
| Profit Growth 5Y (%) | — | — |
| Promoter Holding (%) | — | — |
| Revenue Rank | Rank 4 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |